<DOC>
	<DOCNO>NCT00521157</DOCNO>
	<brief_summary>The purpose clinical trial study efficacy safety naltrexone implant relapse prevention patient complete treatment opiate addiction inpatient ( similarly control ) setting . Participants volunteer study release inpatient treatment , randomize naltrexone implant group waiting-list control duration first six month follow completion inpatient treatment . Both group free receive treatment usual ( TAU ) Norwegian healthcare system . After six month , group offer naltrexone implanted remain six month study . The hypothesis quality life , depression , opioid use , significantly well naltrexone group compare non 6-month follow-up . For last six month trial , investigator hypothesise choice naltrexone implant mainly strengthen positive tendency reverse negative trend aforementioned variable . The investigator also hypothesize implant prevent death opioid overdose 6 month commence treatment .</brief_summary>
	<brief_title>Naltrexone Implants Aid Preventing Relapse Following Inpatient Treatment Opioid Addiction</brief_title>
	<detailed_description />
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>soon complete inpatient treatment opioid addiction live southern Norway psychosis/major depression , currently treat pregnancy liver enzyme : ASAT ALAT &gt; threefold upper boundary maintenance treatment methadone buprenorphine</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Substance abuse</keyword>
	<keyword>Opiate dependency</keyword>
	<keyword>Treatment</keyword>
	<keyword>Relapse prevention</keyword>
</DOC>